Where I see patients (1)
Selected research
-
Clinical Management of Patients With Relapsed/Refractory Multiple Myeloma Treated With Talquetamab.
Clinical lymphoma, myeloma & leukemia
-
Salvage therapies including retreatment with BCMA-directed approaches after BCMA CAR-T relapses for multiple myeloma.
Blood advances
-
International Myeloma Working Group immunotherapy committee consensus guidelines and recommendations for optimal use of T-cell-engaging bispecific antibodies in multiple myeloma.
The Lancet. Oncology
Contact me
- Request appointment
- Refer a patient
- (415) 353-2421